Effects of selenomethionine on acute toxicities from concurrent chemoradiation for inoperable stage III non-small cell lung cancer

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 5

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Clin Oncol. Oct 10, 2015; 6(5): 156-165
Published online Oct 10, 2015. doi: 10.5306/wjco.v6.i5.156

Table 2 Adverse events

Citation: Mix M, Ramnath N, Gomez J, Groot C, Rajan S, Dibaj S, Tan W, Rustum Y, Jameson MB, Singh AK. Effects of selenomethionine on acute toxicities from concurrent chemoradiation for inoperable stage III non-small cell lung cancer. World J Clin Oncol 2015; 6(5): 156-165
URL: https://www.wjgnet.com/2218-4333/full/v6/i5/156.htm
DOI: https://dx.doi.org/10.5306/wjco.v6.i5.156

Mix M, Ramnath N, Gomez J, Groot C, Rajan S, Dibaj S, Tan W, Rustum Y, Jameson MB, Singh AK. Effects of selenomethionine on acute toxicities from concurrent chemoradiation for inoperable stage III non-small cell lung cancer. World J Clin Oncol 2015; 6(5): 156-165 [PMID: 26468452 DOI: 10.5306/wjco.v6.i5.156]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.